These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A rating scale for extrapyramidal side effects. Simpson GM; Angus JW Acta Psychiatr Scand Suppl; 1970; 212():11-9. PubMed ID: 4917967 [No Abstract] [Full Text] [Related]
5. Flupenthixol and trifluoperazine: a double-blind investigation in the treatment of schizophrenics. Gottfries CG Br J Psychiatry; 1971 Nov; 119(552):547-8. PubMed ID: 4944664 [No Abstract] [Full Text] [Related]
6. A double-blind trial of amitriptyline/perphenazine, perphenazine and placebo in chronic withdrawn inert schizophrenics. Collins AD; Dundas J Br J Psychiatry; 1967 Dec; 113(505):1425-9. PubMed ID: 4865295 [No Abstract] [Full Text] [Related]
7. A controlled comparison of the treatment of schizophrenic patients when treated according to the neurologic threshold or by clinical judgment. Simpson GM; Krakov L; Mattke D; St Phard G Acta Psychiatr Scand Suppl; 1970; 212():38-43. PubMed ID: 4917970 [No Abstract] [Full Text] [Related]
8. [Extrapyramidal syndrome and spondyloarthritis ankylopoietica in a schizophrenic patient]. Lipiński B Psychiatr Pol; 1970; 4(2):211-4. PubMed ID: 5427765 [No Abstract] [Full Text] [Related]
9. Predictors of therapeutic responsivity to thiothixene in schizophrenics. Sterlin C; Oliveros R; Ban TA Int Z Klin Pharmakol Ther Toxikol; 1968 Jul; 1(5):394-6. PubMed ID: 4882603 [No Abstract] [Full Text] [Related]
10. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression. Anton RF; Burch EA Am J Psychiatry; 1990 Sep; 147(9):1203-8. PubMed ID: 2201223 [TBL] [Abstract][Full Text] [Related]
13. Amitriptyline-perphenazine interaction in ambulatory schizophrenic patients. A controled study of drug interaction. Chouinard G; Annable L; Serrano M; Albert JM; Charette R Arch Gen Psychiatry; 1975 Oct; 32(10):1295-307. PubMed ID: 1101843 [TBL] [Abstract][Full Text] [Related]
15. [A chronic extrapyramidal syndrome as a complication of neuroleptic therapy]. Gurovich IIa; Fleĭs EP Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(12):1862-8. PubMed ID: 5375563 [No Abstract] [Full Text] [Related]
16. [Transitory exacerbations arising during the course of neuroleptic therapy]. Gurovich IIa Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(6):919-25. PubMed ID: 5471621 [No Abstract] [Full Text] [Related]
17. A controlled clinical trial of amitriptyline added to perphenazine in the treatment of depressed schizophrenics [proceedings]. Prusoff BA; Williams DH; Weissman MM; Astrachan BM Psychopharmacol Bull; 1979 Apr; 15(2):80-1. PubMed ID: 373008 [No Abstract] [Full Text] [Related]
18. The effect of a protriptyline-perphenazine combination in chronic psychiatric patients. St-Jean A; Ban TA; Scott J Curr Ther Res Clin Exp; 1966 Oct; 8(10):483-6. PubMed ID: 4961168 [No Abstract] [Full Text] [Related]
19. Greater than recommended drug dosages--some effects. Kline NS Am J Psychiatry; 1970 Jun; 126(12):1799. PubMed ID: 5441737 [No Abstract] [Full Text] [Related]
20. Pimozide in chronic schizophrenic patients. Huber W; Serafetinides EA; Colmore JP; Clark M J Clin Pharmacol New Drugs; 1971; 11(4):304-9. PubMed ID: 4932748 [No Abstract] [Full Text] [Related] [Next] [New Search]